Michael Dacks

Michael Dacks

Founder en Type 2 Ventures Ltd. .

47 años
Process Industries
Consumer Services
Health Technology

Perfil

Michael Dacks is the founder of Midatadin.com Ltd.
(founded in 2013) and Type 2 Ventures Ltd.
(founded in 2019).
He is currently the President & Chief Operating Officer at Psyence Therapeutics Corp.
(since 2020).
He previously held positions at Vertical Peak Holdings, Inc. as an Independent Director, MedReleaf Corp.
as VP-Legal & International Business Affair (2016-2018), Plena Global Holdings, Inc. as Senior Vice President-Global Affairs (2018-2019), StateHouse Holdings, Inc. as Director (2020-2021), and Psyence Group, Inc. as Chief Operating Officer (2020-2021).
Mr. Dacks received his undergraduate degree from the University of Western Ontario in 1998 and his graduate degree from Osgoode Hall Law School in 2004.

Cargos activos de Michael Dacks

EmpresasCargoInicio
Type 2 Ventures Ltd. Founder 01/04/2019
Psyence Therapeutics Corp. President 01/08/2020
Todos los cargos activos de Michael Dacks

Antiguos cargos conocidos de Michael Dacks.

EmpresasCargoFin
STATEHOUSE HOLDINGS INC. Director/Board Member 31/12/2021
PSYENCE GROUP INC. Chief Operating Officer 01/02/2021
Corporate Officer/Principal 01/07/2019
MEDRELEAF CORP General Counsel 02/09/2018
Midatadin.com Ltd. Founder 01/07/2016
Ver el detalle de la experiencia de Michael Dacks.

Formación de Michael Dacks.

University of Western Ontario Undergraduate Degree
Osgoode Hall Law School Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael Dacks.

Relaciones

100 +

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
VERTICAL PEAK HOLDINGS INC.

Process Industries

STATEHOUSE HOLDINGS INC.

Process Industries

PSYENCE GROUP INC.

Industrial Services

Empresas privadas5

Health Technology

Process Industries

Midatadin.com Ltd.

Type 2 Ventures Ltd.

Psyence Therapeutics Corp.

Ver las conexiones de la empresa